Q1-FY27 · Aras Israeli
The root cause is identified. The success rate is high... somewhere between 80 to 90%. But there is a chance that it will fail. I just want to make sure it's not 100%.
DRREDDY / language trends
Read confidence between the lines.
Dr. Reddy's Laboratories · tone and specificity signals across the available quarters.
Research layer active
Language signals
What changed in management language.
tracked
Q1-FY27 · Aras Israeli
The answer is yes, we did have these issues [R&D productivity]. I believe that we corrected it. Obviously as we know very well the R&D expenses of today's product that we will launch on average 10 to 12 years from now.
Q1-FY27 · MVN
The opportunity is about three to four million pens assuming that we are coming back in November.
Q3-FY26 · Erez Israeli
We are preparing for a launch even in Q4 and there is a scenarios like that and if not it will be in Q1 but let's say anytime between end of February to May we should expect a launch in Canada.
Q3-FY26 · Erez Israeli
You should assume that the old arrangement from Q4 is zero. Doesn't mean that will not sell but let's say just for another generic... it will help everybody.
Q3-FY26 · Erez Israeli
The growth in Russia is sustainable. Not always you'll see 21% growth every quarter but double digit healthy double digit in Russia is absolutely sustainable.